HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hans O Madsen Selected Research

natural resistance-associated macrophage protein 1

3/2007Influence of candidate susceptibility genes on tuberculosis in a high endemic region.
8/2002Natural resistance-associated macrophage protein 1 polymorphisms are associated with microscopy-positive tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hans O Madsen Research Topics

Disease

12Infections
11/2016 - 08/2002
4Neoplasms (Cancer)
01/2022 - 04/2004
4Inflammation (Inflammations)
01/2017 - 05/2007
4Mannose-Binding Protein Deficiency
01/2015 - 03/2002
4Sepsis (Septicemia)
10/2013 - 11/2003
4Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
10/2013 - 11/2003
4Atherosclerosis
01/2012 - 08/2002
4Hematologic Neoplasms (Hematological Malignancy)
09/2011 - 05/2004
3Residual Neoplasm
01/2019 - 01/2016
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018 - 06/2006
3Rheumatoid Arthritis
04/2013 - 02/2002
3Tuberculosis (Tuberculoses)
03/2007 - 08/2002
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2007 - 07/2004
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2006 - 05/2004
1Philadelphia Chromosome
01/2018
1Lymphopenia (Lymphocytopenia)
01/2017
1Endotoxemia
01/2017
1Coinfection
01/2015
1Ischemia
09/2013
1Tetanus
09/2013
1Necrosis
04/2013
1Myocardial Infarction
01/2012
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
09/2008
1Disease Susceptibility (Diathesis)
01/2008
1Pathologic Processes
08/2007
1Hypercholesterolemia
05/2007
1Coronary Stenosis (Coronary Artery Stenosis)
05/2007
1Hyperplasia
10/2006
1Fever (Fevers)
06/2006
1Neutropenia
06/2006
1Pathologic Constriction (Stenosis)
05/2005
1Carotid Artery Diseases
05/2005
1Reperfusion Injury
05/2005
1Cardiovascular Diseases (Cardiovascular Disease)
05/2005
1Critical Illness (Critically Ill)
10/2004
1Genetic Predisposition to Disease (Genetic Predisposition)
10/2004
1Venous Thrombosis (Deep-Vein Thrombosis)
07/2004
1Thrombosis (Thrombus)
07/2004
1Thrombotic Thrombocytopenic Purpura
04/2004
1Falciparum Malaria (Plasmodium falciparum Malaria)
09/2003
1Malaria
09/2003
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2002
1Coronary Artery Disease (Coronary Atherosclerosis)
08/2002
1Pneumococcal Infections
05/2002
1Reinfection
05/2002
1Chronic Disease (Chronic Diseases)
03/2002
1Lung Diseases (Lung Disease)
03/2002
1Cystic Fibrosis (Mucoviscidosis)
03/2002
1Pseudomonas Infections
03/2002

Drug/Important Bio-Agent (IBA)

17Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
09/2015 - 02/2002
6Proteins (Proteins, Gene)FDA Link
01/2012 - 11/2002
5Complement System Proteins (Complement)IBA
09/2013 - 09/2003
4CytokinesIBA
01/2017 - 01/2006
3Biomarkers (Surrogate Marker)IBA
10/2013 - 09/2008
3fludarabineIBA
09/2008 - 04/2004
3AntibodiesIBA
01/2008 - 05/2007
2Interleukin-10 (Interleukin 10)IBA
01/2017 - 01/2006
2HMGB1 Protein (HMG1)IBA
02/2010 - 01/2008
2AntigensIBA
05/2007 - 04/2004
2natural resistance-associated macrophage protein 1IBA
03/2007 - 08/2002
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2018
1Tyrosine Kinase InhibitorsIBA
01/2018
1Imatinib Mesylate (Gleevec)FDA Link
01/2018
1MicroRNAs (MicroRNA)IBA
01/2017
1InterferonsIBA
01/2017
1Interleukin-2 (IL2)IBA
01/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
01/2017
1Interleukin-17 (Interleukin 17)IBA
01/2017
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2016
1Codon (Codons)IBA
01/2015
1Conjugate VaccinesIBA
09/2013
1Messenger RNA (mRNA)IBA
04/2013
1RNA (Ribonucleic Acid)IBA
05/2012
1FicolinsIBA
01/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2007
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
05/2007
1C-Reactive ProteinIBA
05/2007
1LactoferrinIBA
05/2007
1NeopterinIBA
05/2007
1EpitopesIBA
05/2007
1AutoantigensIBA
05/2007
1CollagenIBA
05/2007
1Peptides (Polypeptides)IBA
05/2007
1cyclic citrullinated peptideIBA
05/2007
1Calcitriol Receptors (Calcitriol Receptor)IBA
03/2007
1LectinsIBA
09/2004
1thiamine triphosphorate (TTP)IBA
04/2004
1Opsonin Proteins (Opsonins)IBA
09/2003
1Blood Glucose (Blood Sugar)IBA
09/2003
13' Untranslated Regions (3' UTR)IBA
08/2002

Therapy/Procedure

7Therapeutics
01/2022 - 03/2002
3Cell Transplantation
09/2011 - 01/2006
2Drug Therapy (Chemotherapy)
01/2019 - 06/2006
2Carotid Endarterectomy
10/2006 - 05/2005
1Transplantation
01/2019
1Induction Chemotherapy
06/2006
1Endarterectomy (Thromboendarterectomy)
05/2005
1Hematopoietic Stem Cell Transplantation
05/2004